Health Care/Hospital
Fosun's Innovative Achievements Continue to Make Breakthroughs
Thanks to its Robust Global Ecosystem, Fosun's Various Business Segments Continue to Achieve Growth HONG KONG, June 21, 2022 /PRNewswire/ -- With the resumption of work, production, and business operations inShanghai, the 4th 515 Fosun Family Day, which has been ongoing for more than a month, us...
2022-06-21 17:04
2039
Innovative Business Models in Digital Health Improve Efficiency Across the Care Continuum
Digital health solutions will become inevitable to support better healthcare outcomes at lower costs, says Frost & Sullivan SAN ANTONIO, June 21, 2022 /PRNewswire/ -- The increased number of patients using digital health tools, such as telehealth and other enterprise IT solutions, empowered cons...
2022-06-21 15:12
1614
Innovent and Lilly Jointly Announce the Approval of TYVYT® (sintilimab injection) by China NMPA in Combination with Chemotherapy as First-Line Treatment for Esophageal Squamous Cell Carcinoma
SAN FRANCISCO, INDIANAPOLIS and SUZHOU, China, June 21, 2022 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, autoimmune, metabolic, opht...
2022-06-21 08:00
2715
Shaklee Malaysia Awarded the Trusted Vitamins and Health Supplements Brand in Malaysia
KUALA LUMPUR, Malaysia, June 21, 2022 /PRNewswire/ -- A well-loved vitamins and
health supplements brand, Shaklee has been voted 2022 Trusted Brand inMalaysia
in a survey by Reader's Digest.
2022-06-21 07:00
3837
3Z closes $2 million funding for preclinical development of novel ADHD and Insomnia therapeutics identified by 3Z´s zebrafish drug discovery platform
REYKJAVIK, Iceland, June 20, 2022 /PRNewswire/ -- 3Z, a Reykjavik based drug discovery company is pleased to announce the closure of a$2 million funding round led by seasoned investors in pharmaceuticals and medical technology. The just closed funding will accelerate finalization of preclinical s...
2022-06-20 21:01
1703
Infinitus co-organizes Norm Management Day Event in move to drive growth of the health food sector
GUANGZHOU, China, June 20, 2022 /PRNewswire/ -- On June 16, Chinese herbal health products provider Infinitus (China) Company Ltd. (Infinitus) and Xinhuanet co-hosted the online 2022 Positive Energy Campaign for China's health food industry and the 6.16 Infinitus Norm Management Day Live Broadcas...
2022-06-20 16:37
2676
Onward Therapeutics Made a Second Strategic Equity Investment in Emercell for Their NK Cell Technology in Cancer Immunotherapy
EPALINGES, Switzerland and MONTPELLIER, France, June 20, 2022 /PRNewswire/ -- Onward Therapeutics SA (Onward Therapeutics) and Emercell SAS (Emercell) announced today the recent exercise of Onward Therapeutics' second of three instalments of equity investment in Emercell. With this investment, On...
2022-06-20 12:00
1762
SoniVie receives IDE approval from FDA for its Pilot study to treat Hypertension with its Renal Artery Denervation TIVUS™ technology
TEL AVIV, Israel, June 20, 2022 /PRNewswire/ -- SoniVie, an Israeli company developing a novel proprietary Therapeutic Intra-Vascular Ultrasound System (TIVUS™) to treat a variety of hypertensive disorders, announced that on May 5th 2022 the U.S. Food and Drug Administration granted IDE approval ...
2022-06-20 10:00
1883
HAVAS HEALTH & YOU APPOINTS ELIZABETH EGAN OF HAVAS LYNX TO CEO, HH&Y EUROPE
Appointment Bolsters Capabilities in Fast-Growing European Market Alongside New Havas Lynx Group Leadership NEW YORK, June 17, 2022 /PRNewswire/ -- To support a region that has doubled in size since 2017 and has won over 60% of its pitches in the last year alone, Havas Health & You (HH&Y) today ...
2022-06-17 16:00
2155
Casio to Release Dermatology Camera and Scope in Europe
Following Completion of EU Declaration of Conformity to European MDR TOKYO, June 17, 2022 /PRNewswire/ -- Casio Computer Co., Ltd. announced today that the DZ-D100 Dermatology Camera and DZ-S50 Dermatology Scope conformity studies for European Medical Device Regulations (MDR) have been completed ...
2022-06-17 09:00
1716
Global Cord Blood Corporation Announced Cellenkos Receives FDA Clearance of IND Application for CK0804 as Add on Therapy to Ruxolitinib for the Treatment of Myelofibrosis
HONG KONG, June 17, 2022 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, is pleased to announce that Cellenkos, Inc. ("CLNK"...
2022-06-17 04:20
2837
Insilico Medicine appoints Dr. Feng Ren as co-CEO
Dr. Feng Ren, Chief Scientific Officer (CSO) and head of global research and development is named co-CEO of Insilico Medicine Highlights: * Insilico Medicine is a global, end-to-end, fully-integrated AI-powered biotechnology company with three business models: AI platform, collaboration, and ...
2022-06-16 21:03
3553
Global Cord Blood Corporation Announces Purported EGM Is Not Validly Convened
HONG KONG, June 16, 2022 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO, "GCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, noticed that onJune 3, 2022 Blue Ocean Structure Inv...
2022-06-16 20:30
4234
SPA Villa - Urban Retreat & Beyond at Regent Taipei
In-Room SPA Treatments, Private Fitness Area, Personalized Butler Service, Villa-Type Living Space, and Healthy Dining TAIPEI, June 16, 2022 /PRNewswire/ -- Situated in the heart of Zhongshan district, overlooking the meandering cityscape ofTaipei, Regent Hotel's pristine SPA Villa floor offers ...
2022-06-16 17:13
2097
New research reveals the critical actions needed to ensure COVID-19-driven surge in virtual health and care drives health access and equity in Asia
* COVID-19 pandemic triggered massive surge in virtual health and care delivery across the world, with regions includingAsia embracing hybrid virtual and in-person services * Report from the Broadband Commission for Sustainable Development Working Group on Virtual Health and Care – co-chair...
2022-06-16 15:45
1930
Global Pharmaceutical Market Drives Innovative Digitalization to Accelerate Drug Discovery
According to Frost & Sullivan, digitalization across the pharmaceutical value chain will improve the industry´s efficiency. SAN ANTONIO, June 16, 2022 /PRNewswire/ -- Frost & Sullivan's recent analysis, Global Pharmaceuticals Outlook, finds that the accelerated drug development timelines are driv...
2022-06-16 15:12
1950
Implantica Applauded by Frost & Sullivan for Transforming Gastroesophageal Reflux Disease Treatment with Its Revolutionary Implant RefluxStop™
The RefluxStop™ device prevents the regurgitation of stomach fluid into the esophagus and addresses the limitations of proton pump inhibitors (PPIs) and existing surgical methods and devices for treating acid reflux disease. SAN ANTONIO, June 16, 2022 /PRNewswire/ --– Frost & Sullivan recently a...
2022-06-16 14:00
1606
Sirnaomics Announces Publication of STP705 Clinical Study Results for Treatment of isSCC in the Peer-Reviewed Journal of Drugs in Dermatology
GAITHERSBURG, Md. and SUZHOU, China, June 16, 2022 /PRNewswire/ -- Sirnaomics Ltd. ("Sirnaomics", stock code: 2257.HK), a leading biopharmaceutical company in discovery and development of RNAi therapeutics, announced the peer-reviewed publication of Phase IIa clinical study results of its lead th...
2022-06-16 13:01
2165
GILEAD SCIENCES NEW DATA HIGHLIGHTS PEOPLE LIVING WITH HIV WHO ARE VIRALLY SUPPRESSED EXPERIENCE SIMILAR HEALTH-RELATED QUALITY OF LIFE AS GENERAL POPULATION
– Data in Taiwan Shows That Antiretroviral Therapies Have Helped Transform HIV Into a Chronic Condition and Bring Positive Change in the Outlook for People Living with HIV– SINGAPORE, June 16, 2022 /PRNewswire/ -- Gilead Sciences, Inc. today announced results from an online survey that assessed ...
2022-06-16 11:15
2295
Ascletis Announces Oral Presentation on Updates from Phase IIb Clinical Trial of ASC22, a Subcutaneous PD-L1 Antibody for Functional Cure of Chronic Hepatitis B at EASL ILC 2022
- The updates of ASC22 Phase IIb study will be presented at the oral session during the International Liver Congress™ 2022 onSaturday, June 25, 2022 at 14:15 , Beijing Time (Abstract Number: OS091) HANGZHOU, China and SHAOXING, China, June 16, 2022 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX:1672...
2022-06-16 08:10
2355
Week's Top Stories
Most Reposted
LINKDOOD Breaks Language Barriers, Ushering a New Era for Cross-Border Romance
[Picked up by 326 media titles]
2024-04-29 06:00
Revenue Surpasses 50 Billion: BlueFocus Accelerates Towards the AI Native Era
[Picked up by 276 media titles]
2024-04-23 15:43
INTAMSYS Becomes 3D Printing Equipment Supplier for the WORLDSKILLS LYON 2024 COMPETITION
[Picked up by 274 media titles]
2024-04-24 17:09
Puyuan Fashion Resort 2024: A Grand Unveiling of Global Trends and Local Heritage
[Picked up by 269 media titles]
2024-04-28 09:39
Introducing Wacom Movink: The first OLED pen display, and the thinnest and lightest Wacom pen display ever
[Picked up by 268 media titles]
2024-04-24 13:00
Most Read
Automation Anywhere Appoints Tim McDonough as Chief Marketing Officer to Drive Global Awareness and Growth for the Leader in AI-Powered Automation
2024-04-24 03:57
7855
INTAMSYS Becomes 3D Printing Equipment Supplier for the WORLDSKILLS LYON 2024 COMPETITION
2024-04-24 17:09
6951
Revenue Surpasses 50 Billion: BlueFocus Accelerates Towards the AI Native Era
2024-04-23 15:43
5070